VASODILATION AND INOTROPISM OF THE PHOSPHODIESTERASE INHIBITOR ENOXIMON

1991 | journal article; research paper. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​VASODILATION AND INOTROPISM OF THE PHOSPHODIESTERASE INHIBITOR ENOXIMON​
Holubarsch, C.; Hasenfuß, G. ; Thierfelder, L.; Heiss, H. & Just, H. ​ (1991) 
Zeitschrift für Kardiologie80 pp. 35​-40​.​

Documents & Media

License

GRO License GRO License

Details

Authors
Holubarsch, Christian; Hasenfuß, Gerd ; Thierfelder, L.; Heiss, H.Wolfgang; Just, Hanjörg 
Abstract
The comparison of two invasive studies using intravenous application of the phosphodiesterase enoximone demonstrated unchanged cardiac output in patients with dilated cardiomyopathy NYHA II-III, and increased cardiac output (from 3.22 +/- 1.15 to 5.04 +/- 2.05 l/min; p < 0,01) in acute heart failure. This comparison of hemodynamic parameters in addition to studies on myocardial oxygen consumption support the use of intravenous enoximone in acute heart failure, whereas the long-term application of enoximone in chronic heart failure is judged to be critical.
Issue Date
1991
Publisher
Dr Dietrich Steinkopff Verlag
Journal
Zeitschrift für Kardiologie 
ISSN
0300-5860

Reference

Citations